Type of arteriovenous vascular access and association with patency and mortality
نویسندگان
چکیده
BACKGROUND There are only a few risk factors known for primary patency loss in patients with an arteriovenous graft or fistula. Furthermore, a limited number of studies have investigated the association between arteriovenous access modality and primary patency loss and mortality. The aim of this study was to investigate risk factors for patency loss and to investigate the association between graft versus fistula use and outcomes (patency loss and mortality). METHODS We prospectively followed 919 incident hemodialysis patients and calculated hazard ratios (HRs) for putative risk factors of primary patency loss using Cox regression. Furthermore, HRs were calculated to study the association between graft versus fistula use and two-year primary patency loss and two-year mortality. RESULTS Cardiovascular disease, prior catheter use, lowest tertile of albumin, highest tertile of hsCRP, and lowest tertile of fetuin-A were associated with primary patency loss in both patients with grafts and fistulas. Increased age, female sex, and diabetes mellitus were only associated with primary patency loss in patients with a fistula. We did not observe an association between primary patency loss and BMI, residual GFR, levels of calcium, phosphorus, and total cholesterol. Furthermore, graft use as compared with fistula use was associated with an 1.4-fold (95% CI 1.0-1.9) increased risk of primary patency loss and with an 1.5-fold(95% CI 1.0-2.2) increased mortality risk. CONCLUSION Cardiovascular disease, prior catheter use, albumin, hsCRP, and fetuin-A are risk factors for patency loss. Graft use as compared with fistula use was associated with an increased risk of patency loss and mortality.
منابع مشابه
بررسی میزان کارایی و عوارض گرافت صناعی عروقی پلی تترا فلورو اتیلن در بیماران همودیالیزی
Background: Dialysis access procedures and complications are important causes of morbidity and hospitalization for chronic hemodialysis patients. Ideally, any patient undergoing hemodialysis should receive an autogenous fistula that can be accessed throughout the patient's life. In patients with primarily unsuitable or secondarily surgically-exhausted veins, a prosthetic graft can be performed....
متن کاملVASCULAR ACCESS FOR HEMODIALYSIS: OUR EXPERIENCE WITH 3337 CASES
Over a seven year period from 1982 to 1989,3337 conduits were created in 3137 patients with end stage renal disease (ESRD) as access for chronic dialysis. These included 2690 side-to-side arteriovenous fistulae (A VF), 168 end-to-side A VFs, 10 autogenous vein grafts, 51 homogenous frozen vein grafts, 109 polytetrafluoroethylene (PTFE) grafts, 209 emergency external arteriovenous shunts, t...
متن کاملThe haemodialysis arteriovenous graft: is a new era coming?
The worldwide increase in the incidence and prevalence of haemodialysis (HD) patients is determining the growing demand of vascular access (VA) placement [1]. It is also wellknown that the VA issue imposes a major financial burden on healthcare systems and can be associated with increased morbidity and mortality [2]. VA dysfunction is a major cause of morbidity and mortality in HD patients [3]....
متن کاملSuccessful restoration of arteriovenous dialysis access patency after late intervention
BACKGROUND Arteriovenous dialysis access may be lost due to stenosis and thrombosis. Patency may be restored by thrombectomy or thrombolysis, but this is often not undertaken when the presentation is delayed. The success rate of delayed intervention is largely unknown. METHODS In this single-centre study, we identified all instances of arteriovenous vascular access (VA) failure treated with a...
متن کاملبررسی کارایی یک ساله فیستول های شریانی- وریدی و فاکتورهای پیش بینی کننده آن در بیماران مبتلا به نارسایی مزمن کلیه
Background and purpose: Development of arteriovenous fistulas (AVF) is one of the major advances in the management of patients undergoing hemodialysis. Patency rate of these fistulas and the factors influencing them is of great importance to reduce the costs and rate of repeated hospitalization. Materials and methods: In a five-year study 72 patients who had native AVF were followed for one ye...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 14 شماره
صفحات -
تاریخ انتشار 2013